Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Synthon’s generic version of Copaxone at 40mg receives European approval to treat MS

pharmaceufical-technologyOctober 09, 2017

Tag: synthon , Copaxone , MS

PharmaSources Customer Service